How ultra-processed foods affect eczema in children
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at whether compounds from ultra-processed foods (like packaged snacks and sodas) contribute to eczema (atopic dermatitis) in children. Researchers will compare children with eczema to healthy children of the same age and sex.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 6 months and 10 years old
- Your child must be White/Caucasian
- Your child must have a confirmed diagnosis of atopic dermatitis (eczema) OR be a healthy child without eczema
- Your child cannot have other chronic conditions like severe infections, autoimmune diseases, or certain skin disorders
- Your child cannot have scars, moles, or unusual skin spots on both forearms
- You must sign a consent form allowing your child to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specific diet can help manage mild to moderate eczema. It involves eating whole foods provided by the researchers for a set period and tracking your skin health.
This study looks at how food allergies and eczema (atopic dermatitis) are related. You will have an oral food challenge (eating a small amount of a possible allergen in a safe setting) and give blood and skin samples to help researchers learn more.
This study looks at why disease tends to be more severe in some people with atopic dermatitis (eczema), especially those with a specific genetic change in the IL-4 receptor (IL-4Ra). The results may help explain what drives flare-ups and could guide better treatments in the future.
This study looks at how eczema may be connected to the brain and sleep, using questionnaires and MRI scans. It may help researchers understand what drives symptoms and how treatments could be improved.
This observational study follows people with eczema (atopic dermatitis) and sometimes related allergies over time, even if they keep their usual medical treatments. It may help researchers better understand how these conditions change and what factors relate to symptoms.
This study tests whether an oral medicine (upadacitinib) works as well as a shot (dupilumab) for children aged 2 to 12 with moderate to severe eczema. It aims to see which treatment better controls symptoms like itching and skin rashes.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.